123 related articles for article (PubMed ID: 30890818)
41. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.
Bertoccini L; Sentinelli F; Incani M; Bailetti D; Cimini FA; Barchetta I; Cavallo MG; Cossu E; Lenzi A; Loche S; Baroni MG
Lipids Health Dis; 2017 Sep; 16(1):179. PubMed ID: 28927406
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.
Hubacek JA
Gene; 2016 Oct; 592(1):193-199. PubMed ID: 27496343
[TBL] [Abstract][Full Text] [Related]
44. Genetic Association Between Polycystic Ovary Syndrome and the
Bakhashab S; Batarfi AA; Alhartani MM; Turki R; Mady W
Biomark Insights; 2024; 19():11772719241258585. PubMed ID: 38887365
[TBL] [Abstract][Full Text] [Related]
45. APOA5 Gene Polymorphisms and Cardiovascular Diseases: Metaprediction in Global Populations.
Lin YC; Nunez V; Johns R; Shiao SP
Nurs Res; 2017; 66(2):164-174. PubMed ID: 28252576
[TBL] [Abstract][Full Text] [Related]
46. APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis.
Guardiola M; Cofán M; de Castro-Oros I; Cenarro A; Plana N; Talmud PJ; Masana L; Ros E; Civeira F; Ribalta J
Atherosclerosis; 2015 May; 240(1):98-104. PubMed ID: 25770687
[TBL] [Abstract][Full Text] [Related]
47. Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians.
Kisfali P; Mohás M; Maasz A; Hadarits F; Markó L; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Wittmann I; Melegh B
Circ J; 2008 Jan; 72(1):40-3. PubMed ID: 18159097
[TBL] [Abstract][Full Text] [Related]
48. TCF7-L2 rs7903146 polymorphism in metabolic syndrome with and without acute coronary syndrome.
Zafar U; Khaliq S; Ali Z; Lone KP
J Pak Med Assoc; 2020 Oct; 70(10):1774-1778. PubMed ID: 33159751
[TBL] [Abstract][Full Text] [Related]
49. The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis.
Au A; Griffiths LR; Irene L; Kooi CW; Wei LK
Atherosclerosis; 2017 Oct; 265():60-70. PubMed ID: 28865324
[TBL] [Abstract][Full Text] [Related]
50. Marked Differences of Haplotype Tagging SNP Distribution, Linkage, and Haplotype Profile of APOA5 Gene in Roma Population Samples.
Sumegi K; Duga B; Melegh BI; Banfai Z; Kovesdi E; Maasz A; Melegh B
Pathol Oncol Res; 2017 Oct; 23(4):853-861. PubMed ID: 28102463
[TBL] [Abstract][Full Text] [Related]
51. Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men.
Son KY; Son HY; Chae J; Hwang J; Jang S; Yun JM; Cho B; Park JH; Kim JI
Lipids Health Dis; 2015 Sep; 14():105. PubMed ID: 26365620
[TBL] [Abstract][Full Text] [Related]
52. The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case- control study.
Khella MS; Hamdy NM; Amin AI; El-Mesallamy HO
BMC Med Genet; 2017 Sep; 18(1):101. PubMed ID: 28915859
[TBL] [Abstract][Full Text] [Related]
53. Insulin gene variable number of tandem repeats (INS VNTR) genotype and metabolic syndrome in childhood obesity.
Santoro N; Cirillo G; Amato A; Luongo C; Raimondo P; D'Aniello A; Perrone L; Miraglia del Giudice E
J Clin Endocrinol Metab; 2006 Nov; 91(11):4641-4. PubMed ID: 16868061
[TBL] [Abstract][Full Text] [Related]
54. Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome.
Singmann P; Baumert J; Herder C; Meisinger C; Holzapfel C; Klopp N; Wichmann HE; Klingenspor M; Rathmann W; Illig T; Grallert H
Obes Facts; 2009; 2(4):235-42. PubMed ID: 20054229
[TBL] [Abstract][Full Text] [Related]
55. Quantitative trait loci at the 11q23.3 chromosomal region related to dyslipidemia in the population of Andhra Pradesh, India.
Pranavchand R; Reddy BM
Lipids Health Dis; 2017 Jun; 16(1):116. PubMed ID: 28610615
[TBL] [Abstract][Full Text] [Related]
56. The Relationship Between Vascular Endothelial Growth Factor Cis- and Trans-Acting Genetic Variants and Metabolic Syndrome.
Azimi-Nezhad M; Mirhafez SR; Stathopoulou MG; Murray H; Ndiaye NC; Bahrami A; Varasteh A; Avan A; Bonnefond A; Rancier M; Mehrad-Majd H; Herbeth B; Lamont J; Fitzgerald P; Ferns GA; Visvikis-Siest S; Ghayour-Mobarhan M
Am J Med Sci; 2018 Jun; 355(6):559-565. PubMed ID: 29891039
[TBL] [Abstract][Full Text] [Related]
57. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
[TBL] [Abstract][Full Text] [Related]
58. Kernel machine SNP set analysis finds the association of BUD13, ZPR1, and APOA5 variants with metabolic syndrome in Tehran Cardio-metabolic Genetics Study.
Masjoudi S; Sedaghati-Khayat B; Givi NJ; Bonab LNH; Azizi F; Daneshpour MS
Sci Rep; 2021 May; 11(1):10305. PubMed ID: 33986338
[TBL] [Abstract][Full Text] [Related]
59. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome.
Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B
Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219
[TBL] [Abstract][Full Text] [Related]
60. Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster.
Hsu MC; Chang CS; Lee KT; Sun HY; Tsai YS; Kuo PH; Young KC; Wu CH
Nutr Diabetes; 2013 Mar; 3(3):e61. PubMed ID: 23459084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
